Profile photo Lois Daamen

Lois Daamen

Associate Professor

Strategic program(s):

Biography

[will follow shortly]

Research interests

AI for Early Detection of Isolated Local Pancreatic Cancer Recurrence

In collaboration with Datacation, UMC Utrecht is developing an artificial intelligence (AI) solution for the early detection of isolated local pancreatic cancer recurrence. This project is co-funded by the European Union through the Kansen voor West programme.

Background and challenge

Pancreatic cancer is a highly aggressive malignancy, with >80% of patients developing disease recurrence within two years after surgical resection. Early, accurate detection of recurrence is critical for timely treatment initiation and to reduce uncertainty for patients with regard to their diagnosis and corresponding prognosis. However, on postoperative CT imaging, distinguishing between tumor recurrence and postoperative fibrotic tissue remains challenging, even for experienced radiologists, as both can present with similar radiological characteristics.

AI-based image analysis offers a promising solution by enabling the detection of subtle imaging patterns and facilitating the rapid analysis of large volumes of scans.

Methodological approach and collaboration

Within this collaboration, Datacation has developed an AI model capable of automatic pancreas recognition and segmentation on CT scans after resection. Postoperative anatomical variability presents a substantial challenge: surgical resection often alters pancreatic anatomy, rendering conventional segmentation models suboptimal.

To address this, the developed model employs an encoder-decoder architecture enhanced with an attention mechanism, allowing it to better adapt to inter-patient variability. This work has resulted in a peer-reviewed scientific publication (https://pubmed.ncbi.nlm.nih.gov/41307673/).

Building on this foundation, ongoing work focuses on developing an AI model for automated detection of tumor recurrence following surgery. A key aspect of this development is model explainability. The system is designed to provide visual explanations, highlighting regions within CT images that contribute to classification decisions (e.g., fibrosis versus suspected tumor recurrence). These visualizations aim to support radiologists in interpreting model outputs and enhance trust in clinical decision-making.

Expected impact

This project represents an active collaboration between UMC Utrecht and Datacation, supported by European Union funding. The ultimate goal is to integrate the final AI model into clinical workflows, where it can assist radiologists in evaluating postoperative CT scans.

By enabling faster and more accurate detection of pancreatic cancer recurrence, the approach has the potential to facilitate earlier therapeutic intervention and reduce uncertainty for patients. This may contribute to improved treatment outcomes, increased survival rates, and enhanced quality of life for patients.

 

      

Strategic program(s):

Contact

Research groups

Evaluation of imaging and image-guided Interventions

Research aim

The pace of innovation in (AI driven) imaging/image-guided interventions in oncology is high; the window of opportunity for evaluation narrow. We aim to learn from every patient, in order to facilitate evidence-based implementation of innovation.

Go to group

Recent publications

The impact of age on quality of life, 90-day mortality, adjuvant chemotherapy, and survival after treatment for localized pancreatic cancer J. C.M. Scheepens, K. J. Prinsze, L. G. van Geest, M. G. Besselink, B. A. Bonsing, A. M.E. Bruynzeel, G. A. Cirkel, H. D. Heerkens, I. H. de Hingh, M. Y.V. Homs, J. E. van Hooft, H. W.M. van Laarhoven, L. C. Leeuwenburgh, V. E. de Meijer, G. J. Meijer, I. Q. Molenaar, P. G. Noordzij, H. M.U. Peulen, H. C. van Santvoort, M. W.J. Stommel, R. C. Verdonk, P. A.J. Vissers, C. van Vliet, J. de Vos-Geelen, J. W. Wilmink, M. P.W. Intven, L. A. Daamen, G. Grimbergen,
European journal of cancer, 2026, vol. 242
Radiofrequency Ablation and Chemotherapy vs Chemotherapy Only in Locally Advanced Pancreatic Cancer Leonard W F Seelen, Lilly J H Brada, Marieke S Walma, Steffi J E Rombouts, Manon N Braat, Thomas L Bollen, Inne H Borel Rinkes, Rutger C G Bruijnen, Olivier R Busch, Geert A Cirkel, Lois A Daamen, Freek Daams, Ronald M van Dam, Otto M van Delden, Wouter J M Derksen, Sebastiaan Festen, Karin Groothuis, Jeroen Hagendoorn, Ignace H J T de Hingh, Mathieu D'Hondt, Mike S L Liem, Krijn P van Lienden, Maartje Los, Vincent E de Meijer, Leonie J M Mekenkamp, Maarten W Nijkamp, C Yung Nio, Elizabeth Pando, Gijs A Patijn, Marco B Polée, Wouter W Te Riele, Geert Roeyen, Martijn W J Stommel, Judith de Vos-Geelen, Jan J de Vries, Frank J Wessels, Johanna W Wilmink, Peter M van de Ven, Marc G Besselink, Hjalmar C van Santvoort, I Quintus Molenaar,
JAMA network open, 2026, vol. 9
Does Overall Treatment Time Impact Toxicity and Clinical Outcomes After Magnetic Resonance Imaging-Guided Stereotactic Body Radiotherapy to the Prostate? R L Westley, L A Daamen, F R Teunissen, D Vesprini, A Choudhury, F J Pos, H M Verkooijen, C D Fuller, S Choi, W A Hall, J R N van der Voort van Zyp, J P Christodouleas, A C Tree
Clinical Oncology, 2026, vol. 53
The OligoPanc project Carl Stephan Leonhardt, Mustapha Adham, Shouki Bazarbashi, Irit Ben-Aharon, Regina G.H. Beets-Tan, Ugo Boggi, Thomas B. Brunner, Francesco Cellini, Arturo Chiti, Lois Daamen, Berardino De Bari, Sara De Dosso, Michel Ducreux, Cathy Eng, Massimo Falconi, Cristina R. Ferrone, Isabella Frigerio, Ingrid Garajova, Sabine Gerum, Michael Ghadimi, Thomas Gruenberger, Pascal Hammel, Karin Haustermans, Maria Hawkins, Jin He, Hanne D. Heerkens, Florence Huguet, Martijn P.W. Intven, Ulla Klaiber, Tiuri E. Kroese, Pierre Laurent-Puig, Florian Lordick, Ethan B. Ludmir, Teresa Macarulla, Oscar Matzinger, Alessio G. Morganti, Somnath Mukherjee, Eileen M. O’Reilly, Joon Oh Park, Demetris Papamichael, Per Pfeiffer, José M. Ramia, Falk Roeder, Erika Ruiz-García, Sohei Satoi, Marta Scorsetti, Martin Schneider, Thomas Seufferlein, Alejandro Serrablo, Shailesh V. Shrikhande, Elizabeth C. Smyth, Magali Svrcek, Kyoichi Takaori, Margaret A. Tempero, Natalia S. Tissera, Jeanne Tie, Orlando J.M. Torres, Anthony Turpin, Eric Van Cutsem, Eva Versteijne, Caterina Vivaldi, Zev A. Wainberg, Ralph R. Weichselbaum, Juergen Weitz, Christopher L. Wolfgang, Gerald W. Prager, Oliver Strobel
The Lancet Oncology, 2026, vol. 27, p.e141-e149
Digital solutions, real-world challenges Dominique G. Stuijt, Igor Radanovic, Vasileios Exadaktylos, Ellen Kapiteijn, Tom van der Hulle, Jorg R. Oddens, Erik van Gennep, Lois A. Daamen, Marieke A.R. Bak, M. Corrette Ploem, Martijn G.H. van Oijen, Adriaan D. Bins, Jacobus J. Bosch
Frontiers in Digital Health, 2026, vol. 7
Long-term oncological outcomes following algorithm-based care versus usual care for the early recognition and management of complications after pancreatic resection Thijs J Schouten, Kyra J Prinsze, Anne Claire Henry, Lois A Daamen, Marc G Besselink, Bert A Bonsing, Koop Bosscha, Olivier R Busch, Geert A Cirkel, Ronald M van Dam, Casper H van Eijck, Sebastiaan Festen, Bas Groot Koerkamp, Erwin van der Harst, Ignace H J T de Hingh, Geert Kazemier, Mike S L Liem, Vincent E de Meijer, J Sven D Mieog, Gijs A Patijn, Daphne Roos, Jennifer M J Schreinemakers, Martijn W J Stommel, Fennie Wit, C Henri van Werkhoven, I Quintus Molenaar, F Jasmijn Smits, Hjalmar C van Santvoort,
The Lancet. Gastroenterology & hepatology, 2026, vol. 11, p.323-333